Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-05-08 | Ms. Ashe, age, 61, has been the Chief Business Officer at the New York Genome Center... Ms. Ashe makes valuable contributions to the Board based on over 25 years of experience in the pharmaceutical and biotechnology industry... Compensation Committee is currently comprised of Board members Dr. Burger, Dr. Platzer and Ms. Ashe... The current members of the Corporate Governance and Nominating Committee are Mark Vincent, Carol Ashe and Caroline Loewy... The following table details the compensation received by each director for the year ended December 31, 2018: Carol G. Ashe 28,000 fees earned or paid in cash, 55,278 option awards, total 83,278. |
| 2020-04-24 | Ms. Ashe, age, 62, has been the Chief Business Officer at the New York Genome Center... Ms. Ashe makes valuable contributions to the Board based on over 25 years of experience in the pharmaceutical and biotechnology industry... Compensation Committee is currently comprised of Board members Dr. Burger, Dr. Platzer and Ms. Ashe... The current members of the Corporate Governance and Nominating Committee are Mark Vincent, Carol Ashe and Caroline Loewy... The following table details the compensation received by each non-employee director for the year ended December 31, 2019: Carol G. Ashe 56,000 Fees earned or paid in cash, 51,630 Option awards, Total 107,630. |
| 2021-04-21 | Carol G. Ashe, age, 63, has been the Chief Business Officer at the New York Genome Center... Ms. Ashe received this amount for her services as director on the Board and as a member of the Board’s Corporate Governance and Nominating Committee and Compensation Committee. |
| 2022-04-20 | Ms. Ashe, age 64, has been the Chief Business Officer at the New York Genome Center... Ms. Ashe received this amount for her services as director on the Board and as a member of the Board’s Corporate Governance and Nominating Committee and Compensation Committee. |
| 2023-04-19 | Ms. Ashe earned this amount for her services as director on the Board and as a member of the Board’s Corporate Governance and Nominating Committee and Compensation Committee. |
| 2024-05-15 | Ms. Ashe, age 66, has been the Chief Business Officer at the New York Genome Center... she is a member of the Audit Committee, Nominating and Corporate Governance Committee and Chair of the Compensation Committee... Ms. Ashe earned $80,000 for her services as director on the Board and as a member of the Board's Corporate Governance and Nominating Committee and Compensation Committee. Total compensation $123,669. |
| 2024-07-17 | Named Executive Officers and Directors Carol G. Ashe 21,163 Shares beneficially owned Does not exceed one percent of Shares outstanding |
| 2024-12-30 | Name of Beneficial Owner Named Executive Officers and Directors Carol G. Ashe 25,330 * |
Data sourced from SEC filings. Last updated: 2026-02-03